Defective DNA mismatch repair determines a characteristic transcriptional profile in proximal colon cancers.

BACKGROUND & AIMS Colon cancers with defective DNA mismatch repair (MMR) have peculiar molecular, pathologic, and clinical features, including high-level microsatellite instability, conspicuous lymphocytic infiltration, preferential location in the proximal colon, and better prognosis. Our aim was to characterize the transcriptional profile of this colon cancer subset. METHODS An oligonucleotide microarray containing 12,625 probes was used to evaluate gene expression in 25 proximal colon cancers, 10 samples of normal colon mucosa, and 14 colon cancer cell lines. Transcriptional profiles of MMR-deficient cancers and cell lines were compared with those of their MMR-proficient counterparts. RESULTS Unsupervised analysis of microarray data showed that MMR status exerts a predominant influence on the gene expression profile of proximal colon cancers. Hierarchical clustering divided the cancers into 2 groups corresponding almost perfectly with their MMR status. Supervised analysis identified numerous gene expression changes that represent a genetic signature of MMR-deficient colon cancers. Changes in genes involved in apoptosis and the immune response were consistent with the better prognosis of MMR-deficient cancers. In MMR-deficient cancers and cell lines, 4-1BBL, a crucial gene in the anti-tumor immune response, was, respectively, 2.4 and 6.0 times more expressed than in their MMR-proficient counterparts. This difference was confirmed by quantitative reverse-transcription polymerase chain reaction and flow cytometric assessment of 4-1BBL protein expression in colon cancer cell lines. Our analysis also showed novel possible gene targets of microsatellite instability. CONCLUSIONS MMR inactivation produces distinct changes in the cellular messenger RNA pool, which is consistent with a unique tumorigenesis pathway.

[1]  Josef Jiricny,et al.  Immunohistochemical analysis reveals high frequency of PMS2 defects in colorectal cancer. , 2005, Gastroenterology.

[2]  P. Schlag,et al.  Different sialyltransferase activities in human colorectal carcinoma cells from surgical specimens detected by specific glycoprotein and glycolipid acceptors , 1994, Clinical & Experimental Metastasis.

[3]  V. Ambros.  The functions of animal microRNAs , 2004, Nature.

[4]  Xia Han,et al.  Colorectal cancers with microsatellite instability display mRNA expression signatures characteristic of increased immunogenicity , 2004, Molecular Cancer.

[5]  T. Hulsebos,et al.  Amplification and overexpression of genes in 17p11.2 ~ p12 in osteosarcoma. , 2004, Cancer genetics and cytogenetics.

[6]  A. C. Williams,et al.  Hedgehog signalling in colorectal tumour cells: Induction of apoptosis with cyclopamine treatment , 2004, International journal of cancer.

[7]  R W M Collins,et al.  Human MHC class I chain related (MIC) genes: their biological function and relevance to disease and transplantation. , 2004, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.

[8]  A. Fields,et al.  Protein Kinase C (PKC) βII Induces Cell Invasion through a Ras/Mek-, PKCι/Rac 1-dependent Signaling Pathway* , 2004, Journal of Biological Chemistry.

[9]  I. Hirata,et al.  Analysis of pathological risk factors for lymph node metastasis of submucosal invasive colon cancer , 2004, Modern Pathology.

[10]  Boris Zhivotovsky,et al.  DNA damage-induced apoptosis , 2004, Oncogene.

[11]  F. Kaye,et al.  Thymidylate synthase as an oncogene: a novel role for an essential DNA synthesis enzyme. , 2004, Cancer cell.

[12]  A. Fields,et al.  Protein kinase Cι is required for Ras transformation and colon carcinogenesis in vivo , 2004, The Journal of cell biology.

[13]  G. Mufti,et al.  Role of 4-1BB:4-1BB ligand in cancer immunotherapy , 2004, Cancer Gene Therapy.

[14]  Maria Laura Belladonna,et al.  Potent Antitumor Activity of Interleukin-27 , 2004, Cancer Research.

[15]  H. Auer,et al.  Tissue-Wide Expression Profiling Using cDNA Subtraction and Microarrays to Identify Tumor-Specific Genes , 2004, Cancer Research.

[16]  S. Markowitz,et al.  Manipulation of nonsense mediated decay identifies gene mutations in colon cancer Cells with microsatellite instability , 2004, Oncogene.

[17]  J. Jiricny,et al.  Mismatch repair-dependent transcriptome changes in human cells treated with the methylating agent N-methyl-n'-nitro-N-nitrosoguanidine. , 2003, Cancer research.

[18]  M. Oka,et al.  Detection of amplified oncogenes by genome DNA microarrays in human primary esophageal squamous cell carcinoma: comparison with conventional comparative genomic hybridization analysis. , 2003, Cancer genetics and cytogenetics.

[19]  J. Lieberman,et al.  Nuclear war: the granzyme A-bomb. , 2003, Current opinion in immunology.

[20]  David W. Anderson,et al.  EDD, the human orthologue of the hyperplastic discs tumour suppressor gene, is amplified and overexpressed in cancer , 2003, Oncogene.

[21]  B. Leggett,et al.  The impact of microsatellite instability on the molecular phenotype of colorectal tumors. , 2003, Cancer research.

[22]  F. Domann,et al.  Mutant p53 and aberrant cytosine methylation cooperate to silence gene expression , 2003, Oncogene.

[23]  Stephen B Fox,et al.  The angiogenic switch for vascular endothelial growth factor (VEGF)‐A, VEGF‐B, VEGF‐C, and VEGF‐D in the adenoma–carcinoma sequence during colorectal cancer progression , 2003, The Journal of pathology.

[24]  T. Iwanaga,et al.  Purification and identification of a binding protein for pancreatic secretory trypsin inhibitor: a novel role of the inhibitor as an anti-granzyme A. , 2003, The Biochemical journal.

[25]  J. Jiricny,et al.  Methylation‐induced G2/M arrest requires a full complement of the mismatch repair protein hMLH1 , 2003, The EMBO journal.

[26]  Edward M. Johnson.  The Pur protein family: clues to function from recent studies on cancer and AIDS. , 2003, Anticancer research.

[27]  W. Lindenmaier,et al.  Provision of 4-1BB Ligand Enhances Effector and Memory CTL Responses Generated by Immunization with Dendritic Cells Expressing a Human Tumor-Associated Antigen1 , 2003, The Journal of Immunology.

[28]  S. L. Carrithers.  Diarrhea or colorectal cancer: Can bacterial toxins serve as a treatment for colon cancer? , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[29]  Hsien-yu Wang,et al.  Overexpression of mitogen-activated protein kinase phosphatases MKP1, MKP2 in human breast cancer. , 2003, Cancer letters.

[30]  O. Coqueret,et al.  New roles for p21 and p27 cell-cycle inhibitors: a function for each cell compartment? , 2003, Trends in cell biology.

[31]  Vasudevan Seshadri,et al.  Translational control by the 3'-UTR: the ends specify the means. , 2003, Trends in biochemical sciences.

[32]  M. Ramachandra,et al.  Restoration of transforming growth factor Beta signaling by functional expression of smad4 induces anoikis. , 2002, Cancer research.

[33]  B. Leggett,et al.  Emerging concepts in colorectal neoplasia. , 2002, Gastroenterology.

[34]  D. Berger.  Plasmin/Plasminogen System in Colorectal Cancer , 2002, World Journal of Surgery.

[35]  Y. Sasaki,et al.  Identification of the Osteopontin gene as a direct target of TP53 , 2002, Genes, chromosomes & cancer.

[36]  Cynthia Cohen,et al.  Reactive oxygen generated by Nox1 triggers the angiogenic switch , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[37]  Michael A. Choti,et al.  A Phosphatase Associated with Metastasis of Colorectal Cancer , 2001, Science.

[38]  A. Stadnyk,et al.  Endogenous IL-1 and type II IL-1 receptor expression modulate anoikis in intestinal epithelial cells. , 2001, Experimental cell research.

[39]  D Gautheret,et al.  Identification of alternate polyadenylation sites and analysis of their tissue distribution using EST data. , 2001, Genome research.

[40]  M. Leppert,et al.  Microsatellite instability in sporadic colon cancer is associated with an improved prognosis at the population level. , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[41]  A. Chott,et al.  Mutations in apoptosis genes: a pathogenetic factor for human disease. , 2001, Mutation research.

[42]  C. Schneider,et al.  The death substrate Gas2 binds m‐calpain and increases susceptibility to p53‐dependent apoptosis , 2001, The EMBO journal.

[43]  S. Arii,et al.  Human macrophage metalloelastase gene expression in colorectal carcinoma and its clinicopathologic significance , 2001, Cancer.

[44]  S. Peltz,et al.  The cap-to-tail guide to mRNA turnover , 2001, Nature Reviews Molecular Cell Biology.

[45]  J. Jass.  Familial colorectal cancer: pathology and molecular characteristics. , 2000, The Lancet. Oncology.

[46]  F. Lee,et al.  Constitutive Expression of Functional 4-1BB (CD137) Ligand on Carcinoma Cells1 , 2000, The Journal of Immunology.

[47]  Lieping Chen,et al.  Immunomodulatory gene therapy with interleukin 12 and 4-1BB ligand: long- term remission of liver metastases in a mouse model. , 2000, Journal of the National Cancer Institute.

[48]  L. Presta,et al.  Inhibitory Fc receptors modulate in vivo cytoxicity against tumor targets , 2000, Nature Medicine.

[49]  G. Marra,et al.  Recognition of DNA alterations by the mismatch repair system. , 1999, The Biochemical journal.

[50]  J. Herman,et al.  Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[51]  J C Reed,et al.  Somatic Frameshift Mutations in the BAX Gene in Colon Cancers of the Microsatellite Mutator Phenotype , 1997, Science.

[52]  L. Aaltonen,et al.  Better survival rates in patients with MLH1-associated hereditary colorectal cancer. , 1996, Gastroenterology.

[53]  C. Boland,et al.  Hereditary nonpolyposis colorectal cancer: the syndrome, the genes, and historical perspectives. , 1995, Journal of the National Cancer Institute.

[54]  B Calabretta,et al.  Overexpression of DR-nm23, a protein encoded by a member of the nm23 gene family, inhibits granulocyte differentiation and induces apoptosis in 32Dc13 myeloid cells. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[55]  K. Kinzler,et al.  Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability. , 1995, Science.

[56]  H. Thomas.  Familial colorectal cancer. , 1993, BMJ.

[57]  Darryl Shibata,et al.  Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis , 1993, Nature.

[58]  R. Elston,et al.  Hereditary nonpolyposis colorectal cancer (lynch syndromes I and II). I. Clinical description of resource , 1985, Cancer.